Lin S, Mansfield J, Rao X, Jiang W, Fang P, Roman K, Wang C, Komaki R, Hahn S, Swisher SG , Fujimoto J, Wistuba I, Wang J, Hoyt C
Optimized production of insulin variant, a recombinant platelet aggregation inhibitor, by high cell-density fermentation of recombinant Escherichia coli
Russo A, Tellone E, Barreca D, Ficarra S, Lagan G
Prior to the testing the drug on people with alopecia, the researchers tested two FDA-approved JAK inhibitors ruxolitinib and tofacitinib on mice with extensive hair loss from the disease, and found that the drugs effectively stopped the attack of T cells on hair follicles
Oral administration reshapes the prior-auth and site-of-care conversation entirely
The vial sits on the counter